Trial Profile
A retrospective study in HIV-infected patients who switched to cobicistat/darunavir single tablet regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 30 Dec 2016 New trial record